To research whether circFTO could promote NSCLC cell glycolysis and progression through miR-148a-3p/PDK4 axis, we performed a Seahorse assay and relevant functional tests relating to glucose metabolism. The gene discussed is PDK4; the disease is non-small cell lung carcinoma.